StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly GAAP gross margin (% of revenue) by Quarter

GAAP gross margin (% of revenue) (%)

QuarterlyAnnual

Eli Lilly GAAP gross margin (% of revenue): 85.8% in Q2 2026, up 1.5 pts from a year earlier. That is the highest of the 33 quarters on record here.

Latest, Q2 2026
85.8%
Period ended Jun 30, 2026
Change on a year earlier
+1.5 pts
84.3% in Q2 2025
History
33 quarters
Since Q1 2017
Sources
29
Documents cited below

Where the Q2 2026 figure comes from

“|| Gross margin as a percent of revenue | 85.8 | % | 84.3 | % | 84.0 | % | 83.5 | %”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A & Form 8-K Earnings Releases.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP gross margin (% of revenue) (%)Year on yearSource
Q2 2026Jun 30, 202685.8%+1.5 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202681.9%-0.6 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q4 2025Dec 31, 202582.5%+0.3 ptsEarnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 202582.9%+1.9 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 202584.3%+3.5 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 202582.5%+1.6 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202482.2%+1.3 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 202481.0%+0.6 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 202480.8%+2.5 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 202480.9%+4.3 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 202380.9%+2.1 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202380.4%+3.1 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 202378.3%+0.3 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 202376.6%+3.1 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 202278.8%–Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2022Sep 30, 202277.3%-1.6 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Eli Lilly GAAP gross margin (% of revenue) (%), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gm-gaap-pct

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.